KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

Market Cap	155.97B
Revenue (ttm)	81.28B
Net Income (ttm)	3.79B
Shares Out	10.91M
EPS (ttm)	348.00
PE Ratio	41.09
Forward PE	n/a
Dividend	50.00 (0.35%)
Ex-Dividend Date	Dec 27, 2024

Volume	10,708
Average Volume	7,973
Open	14,210
Previous Close	14,220
Day's Range	14,050 - 14,210
52-Week Range	13,050 - 24,650
Beta	1.18
RSI	47.00
Earnings Date	n/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 134
• Stock Exchange: KOSDAQ
• Ticker Symbol: 032300

Financial Performance

In 2024, KOREA PHARMA's revenue was 81.28 billion, a decrease of -2.36% compared to the previous year's 83.24 billion. Earnings were 3.79 billion, an increase of 4426.69%.